Sequeira, L.; Benfeito, S.; Fernandes, C.; Lima, I.; Peixoto, J.; Alves, C.; Machado, C.S.; Gaspar, A.; Borges, F.; Chavarria, D.
Drug Development for Alzheimer’s and Parkinson’s Disease: Where Do We Go Now? Pharmaceutics 2024, 16, 708.
https://doi.org/10.3390/pharmaceutics16060708
AMA Style
Sequeira L, Benfeito S, Fernandes C, Lima I, Peixoto J, Alves C, Machado CS, Gaspar A, Borges F, Chavarria D.
Drug Development for Alzheimer’s and Parkinson’s Disease: Where Do We Go Now? Pharmaceutics. 2024; 16(6):708.
https://doi.org/10.3390/pharmaceutics16060708
Chicago/Turabian Style
Sequeira, Lisa, Sofia Benfeito, Carlos Fernandes, Inês Lima, Joana Peixoto, Catarina Alves, Cláudia Sofia Machado, Alexandra Gaspar, Fernanda Borges, and Daniel Chavarria.
2024. "Drug Development for Alzheimer’s and Parkinson’s Disease: Where Do We Go Now?" Pharmaceutics 16, no. 6: 708.
https://doi.org/10.3390/pharmaceutics16060708
APA Style
Sequeira, L., Benfeito, S., Fernandes, C., Lima, I., Peixoto, J., Alves, C., Machado, C. S., Gaspar, A., Borges, F., & Chavarria, D.
(2024). Drug Development for Alzheimer’s and Parkinson’s Disease: Where Do We Go Now? Pharmaceutics, 16(6), 708.
https://doi.org/10.3390/pharmaceutics16060708